Skip to main content
. 2020 Dec 1;11:5922. doi: 10.1038/s41467-020-19801-x

Fig. 4. 96-week treatment outcomes among participants in the ADVANCE Trial divided by treatment arm, presence or absence of WHO-defined pretreatment drug resistance, and achievement of greater than vs less than 95% adherence based on pharmacy pill count.

Fig. 4

Error bars represent 95% confidence intervals of the proportion estimates.